The effectiveness of risperidone on PANSS score and IL-6 in confirmed COVID-19 schizophrenic patients. Healthcare in Low-resource Settings, [S. l.], v. 13, n. 1, 2024. DOI: 10.4081/hls.2024.12723. Disponível em: https://www.pagepressjournals.org/hls/article/view/12723. Acesso em: 17 apr. 2026.